Gilead Sciences agreed to acquire Arcellx in a deal valued at approximately $7.8 billion in total, deepening its push into cell therapy for multiple myeloma.

Anito-cel is a BCMA-directed CAR T-cell therapy. Back in 2019, Gilead spent $11.9 billion to buy another CAR-T developer called Kite Therapeutics, which had one of the first CAR-T therapies ever ...

This is Gilead's biggest deal since its $21 billion buyout of Immunomedics, giving it access to Trodelvy, an antibody-drug ...

Landing on the only FAA-registered ice runway in the continental U.S. has become a bucket-list item for pilots from all over the country. But its future may be melting away.

A SpaceX Falcon 9 rocket is set to launch 29 Starlink satellites from Florida's Space Coast. Here's when and where to watch ...

Gilead has struck a deal to buy Arcellx for $7.8 billion to take full control of a CAR-T cell therapy that is on the cusp of approval.

Dance floors may be emptier, but Singapore is coming alive at night with outdoor K-pop parties, midnight seafood hunts and more. The programme, On The Red Dot, encounters a different side to the city ...

Intergenerational inequality will only be dealt with by taxing the people that have the money, not by cutting the taxes of those who don't have it.

If launched in 2035, a spacecraft performing such a maneuver could fly by 3I/ATLAS by 2085. When you purchase through links ...

A SpaceX Falcon 9 booster is set to take off on another record-breaking mission Saturday night. Here's what to know before ...

Astronauts could be two weeks away from venturing to the moon for the first time in more than 50 years. They'll launch on a ...

Technicians swapped seals at the launch pad after hydrogen gas leaked from the rocket’s main fueling line earlier this month.